Drug Trial Radar · NCT06616766
A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946
Last checked: Nov 19, 2026Latest source record: Aug 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
201
Planned (sponsor's estimate)
Start
Oct 2, 2024
Primary completion
Mar 15, 2028
Study completion Jul 29, 2028
Sponsor
- Lead sponsor
- Yuhan CorporationIndustry
- Sponsor type
- Industry
- First posted
- Sep 27, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Not applicable (single group)
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this YH42946-101 is to evaluate the safety, Tolerability, Pharmacokinetics and anti-tumor activity of YH42946 in patients with locally advanced of metastatic solid tumors with HER2 aberration and EGFR exon 20 insertions.
Conditions
- NSCLC (Non-small Cell Lung Cancer)
- Solid Tumor
Interventions
YH42946Drug
YH42946
Primary outcomes
What the sponsor says the trial is designed to measure.
- Treatment Emergent Adverse Events(TEAE)sTime frame: Through study completion, during the first 21 days of DLT evaluation period.
- Objective Response Rate (ORR)Time frame: Through dose expansion part completion, approximately 12 months
Locations
8 sites in 2 countries. Site status is shown where the registry gives one.
Next Oncology Virginia
Fairfax, Virginia · Terminated
Seoul National University Hospital
Seoul, South Korea · Recruiting
Severance Hospital, Yonsei University
Seoul, South Korea · Recruiting
Samsung Medical Center
Seoul, South Korea · Recruiting
Asan Medical Center, University of Ulsan
Seoul, South Korea · Recruiting
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea · Recruiting
The Catholic Univ. of Korea St. Vincent's Hospital
Suwon, Gyeonggi-do, South Korea · Recruiting
Chungbuk National University Hospital
Cheongju-si, North Chungcheong, South Korea · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.